Production (Stage)
Elanco Animal Health Incorporated
ELAN
$13.81
-$0.36-2.54%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.19B | 1.02B | 1.03B | 1.18B | 1.21B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.19B | 1.02B | 1.03B | 1.18B | 1.21B |
| Cost of Revenue | 509.00M | 501.00M | 492.00M | 495.00M | 515.00M |
| Gross Profit | 684.00M | 519.00M | 538.00M | 689.00M | 690.00M |
| SG&A Expenses | 341.00M | 294.00M | 323.00M | 354.00M | 337.00M |
| Depreciation & Amortization | 128.00M | 130.00M | 133.00M | 131.00M | 133.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.07B | 1.01B | 1.04B | 1.07B | 1.07B |
| Operating Income | 121.00M | 14.00M | -5.00M | 115.00M | 133.00M |
| Income Before Tax | 60.00M | -51.00M | 559.00M | -32.00M | 12.00M |
| Income Tax Expenses | -7.00M | -43.00M | 195.00M | 18.00M | -20.00M |
| Earnings from Continuing Operations | 67.00M | -8.00M | 364.00M | -50.00M | 32.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 67.00M | -8.00M | 364.00M | -50.00M | 32.00M |
| EBIT | 121.00M | 14.00M | -5.00M | 115.00M | 133.00M |
| EBITDA | 282.00M | 138.00M | 165.00M | 277.00M | 299.00M |
| EPS Basic | 0.14 | -0.02 | 0.74 | -0.10 | 0.06 |
| Normalized Basic EPS | 0.09 | -0.06 | -0.08 | 0.06 | 0.07 |
| EPS Diluted | 0.13 | -0.02 | 0.73 | -0.10 | 0.06 |
| Normalized Diluted EPS | 0.09 | -0.06 | -0.08 | 0.06 | 0.07 |
| Average Basic Shares Outstanding | 495.10M | 494.40M | 494.30M | 494.20M | 493.20M |
| Average Diluted Shares Outstanding | 499.10M | 494.40M | 497.70M | 494.20M | 496.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |